Back

Real-world evidence complements randomised controlled trial data to inform daily clinical practice.

26 August 2022 (15:35 - 15:50)
Organised by:
Congress Presentation Part of: Real-world evidence in practice: stroke prevention with non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation Atrial Fibrillation (AF) Open Access ESC Congress 2022

About the speaker

Photo
Doctor Steven Deitelzweig

Ochsner Medical Center, New Orleans (United States of America)

3 More presentations in this session

Presentation thumbnail
What can robust real-world evidence bring to the table?
Professor G. Lip (Liverpool, GB)
Slides Video
Presentation thumbnail
Stroke prevention in sub-populations of patients with non-valvular atrial fibrillation.
Professor G. Lip (Liverpool, GB)
Slides Video
Presentation thumbnail
Audience participation.
Professor G. Lip (Liverpool, GB)
Slides Video

Access the full session

Session thumbnail
Real-world evidence in practice: stroke prevention with non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation
Video

The Event

Event poster

ESC Congress 2022

26 August 2022 15:35 CET
You may be interested in
thumbnail
Congress Presentation
Adherence and treatment satisfaction among atrial fibrillation patients treated with VKAs versus NOACs: real-world data from a single-center cohort
thumbnail
Congress Presentation
From prescription to outcome: real-world utilization of direct oral anticoagulants in atrial fibrillation across Europe
thumbnail
Congress Presentation
Trends in clinical outcomes of patients with incident atrial fibrillation; results from a nationwide registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources